(Q71603193)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

main subject

angiogenesis inhibitor

1 reference

J Folkman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

H Brem

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

I Gresser

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

J Grosfeld

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

language of work or name

English

0 references

publication date

1 October 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pediatric Surgery

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

1253-1257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json

Tumor angiogenesis: therapeutic implications

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

What Is the Evidence That Tumors Are Angiogenesis Dependent?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

What is the role of angiogenesis in metastasis from cutaneous melanoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Mechanisms of Endothelial Growth Control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Successful treatment of an angiogenic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Analysis of experimental antiangiogenic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Effectiveness of mouse interferon alpha/beta compared to single-agent chemotherapy in increasing survival time of mice after intravenous inoculation of Friend erythroleukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Inhibition of Cell Motility by Interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Active Cancer Therapy Combining 13-cis-Retinoic Acid With Interferon-

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

A new activity of herbimycin A: inhibition of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Antitumor effect of GPA1734 in rat Walker 256 carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Identification of an Inhibitor of Neovascularization from Cartilage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Regulators of Angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

Inhibitors of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

A method for the large scale production of potent interferon preparations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980308-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3468(05)80308-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7505321%20AND%20SRC:MED&resulttype=core&format=json